Thus, the average proportion of vimentin-positive cells increased by 16.6 ± 5.4% in 13 patients with partial tumor regression and by only 10.3 ± 3.0% in 22 patients with complete regression (p = 0.16). This evidence concerns the gene VIM and neoplasm.